-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

603.O3.6 603. Oncogenes and Tumor Suppressors: Epigenetic Transformation in Myeloid and Lymphoid Malignancies

Oncogenes and Tumor Suppressors Program: Oral and Poster Abstracts
Type: Oral
Sunday, December 6, 2015: 4:30 PM-6:00 PM
W308, Level 3 (Orange County Convention Center)
Moderators:
Tobias Neff, MD, Children's Hospital Colorado and Gang Huang, PhD, Cincinnati Children's Hospital Medical Center

Disclosures:
Neff: Epizyme: Patents & Royalties: US Patent 62/026583 Dot1l Inhibition in Patients with MN1 High AML filed 7/2014 Coinventor: Tobias Neff .
4:30 PM

Sarah C Nabinger, PhD1*, Michihiro Kobayashi, MD, PhD1*, Rui Gao, PhD1*, Sisi Chen, BS2, Chonghua Yao, MD1*, Feng-Chun Yang, MD, PhD3 and Yan Liu, PhD1

1Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN
2Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN
3Department of Biochemistry and Molecular Biology & Sylvester Comprehensive Cancer Center, University of Miami Leonard M. Miller School of Medicine, Miami, FL

4:45 PM

Goro Sashida, MD, PhD1,2, Changshan Wang, MD, PhD2*, Daisuke Sato, MS2*, Motohiko Oshima, PhD2 and Atsushi Iwama, MD, PhD2

1International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan
2Department of Cellular and Molecular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan

5:00 PM

Hein Schepers, PhD1, Patrick Korthuis, MSc1*, Marjan Geugien, MSc1*, Jennifer Jaques, MSc1*, Tihomira I. Todorova, MSc2*, Ulrich Steidl, MD, PhD2, Jan Jacob Schuringa, PhD3 and Edo Vellenga, MD, PhD1

1Department of Experimental Hematology, University Medical Center Groningen, Groningen, Netherlands
2Department of Cell Biology, Albert Einstein College of Medicine, New York, NY
3Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

5:15 PM

Zhenhua Yang, PhD*, Kushani Shah*, Jonathan Augustin*, Jing Hu, PhD* and Hao Jiang, PhD

Department of Biochemistry and Molecular Genetics, UAB Stem Cell Institute, University of Alabama at Birmingham, Birmingham, AL

5:30 PM

Daniel Sasca, MD1,2*, Andrea Schueler, PhD1*, Jakub Szybinski1*, Oliver Kriege, MD1*, Kerstin Kunz1*, Eva Marie Fehr, MD1*, Patricia Haehnel, PhD1*, Wolf Henning Gebhardt, PhD3*, Gerge Reid, PhD3*, Matthias Theobald, MD, PhD1, Lars Bullinger, MD4 and Thomas Kindler, MD1*

1University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
2Cambridge Institute of Medical Research, University of Cambridge, Cambridge, United Kingdom
3Institute of Molecular Biology, Mainz, Germany
4University of Ulm, Ulm, Germany

5:45 PM

Colleen E. Annesley, MD1, Amy S. Duffield, MD, PhD2, Rachel E. Rau, MD3, Gregory McCarty1*, Daniel Magoon1*, Li Li, MD, PhD4, Vicki Huff, PhD5*, Donald Small, MD, PhD6, David Loeb, MD, PhD1* and Patrick Brown, MD1

1Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD
2Pathology, Johns Hopkins University School of Medicine, Baltimore, MD
3Department of Pediatrics, Baylor College of Medicine, Houston, TX
4Oncology, Johns Hopkins University School of Medicine, Baltimore, MD
5Department of Molecular Genetics/Cancer Genetics, University of Texas/M.D. Anderson Cancer Center, Houston, TX
6Oncology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD

*signifies non-member of ASH